Simona King - Aug 23, 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)

Role
Chief Financial Officer
Signature
/s/ Edgar Cale, Attorney-in-Fact
Stock symbol
PASG
Transactions as of
Aug 23, 2021
Transactions value $
$0
Form type
4
Date filed
8/25/2021, 06:44 PM
Next filing
Feb 14, 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PASG Employee Stock Option (Right to Buy) Award $0 +360K $0.00 360K Aug 23, 2021 Common Stock 360K $11.43 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests as to 25% of the total shares on August 23, 2022, then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 23, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.